Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Total Liabilities: 2018-2019

Historic Total Liabilities for DiaMedica Therapeutics (DMAC) over the last 2 years, with Sep 2019 value amounting to $1.3 million.

  • DiaMedica Therapeutics' Total Liabilities rose 132.58% to $1.3 million in Q3 2019 from the same period last year, while for Sep 2019 it was $1.3 million, marking a year-over-year increase of 132.58%. This contributed to the annual value of $1.3 million for FY2018, which is N/A change from last year.
  • As of Q3 2019, DiaMedica Therapeutics' Total Liabilities stood at $1.3 million, which was up 22.28% from $1.1 million recorded in Q2 2019.
  • DiaMedica Therapeutics' Total Liabilities' 5-year high stood at $1.6 million during Q1 2019, with a 5-year trough of -$6.7 million in Q1 2018.
  • Over the past 2 years, DiaMedica Therapeutics' median Total Liabilities value was $1.1 million (recorded in 2019), while the average stood at -$1.6 million.
  • Data for DiaMedica Therapeutics' Total Liabilities shows a peak YoY soared of 132.58% (in 2019) over the last 5 years.
  • Quarterly analysis of 2 years shows DiaMedica Therapeutics' Total Liabilities stood at $1.3 million in 2018, then surged by 132.58% to $1.3 million in 2019.
  • Its Total Liabilities stands at $1.3 million for Q3 2019, versus $1.1 million for Q2 2019 and $1.6 million for Q1 2019.